Skip to Content

Join the 'Rapivab' group to help and get support from people like you.

Rapivab News

HIV Treatment Protects Uninfected Partner From the Virus

Posted 26 Jul 2017 by Drugs.com

TUESDAY, July 25, 2017 – HIV treatment prevented transmission of the virus in gay couples when only one partner had the virus, a new study shows. The research included 358 such gay couples in Australia, Brazil and Thailand. The HIV-positive partners received treatment that reduced the amount of virus in the blood to undetectable levels. The participants were followed from 2012 to 2016. During that time, the couples reported nearly 17,000 instances of anal intercourse without a condom. None resulted in HIV transmission, the study authors said. "Undetectable virus level effectively prevents HIV transmission among gay couples," said chief study investigator Andrew Grulich, a professor at the Kirby Institute at the University of New South Wales in Australia. "This is life-changing news for couples of differing HIV status. But it is important that the HIV positive partner is under regular ... Read more

Related support groups: HIV Infection, Tamiflu, Pre-Exposure Prophylaxis, Incivek, Truvada, Baraclude, Victrelis, Oseltamivir, Viread, Tenofovir, Kaletra, Norvir, Entecavir, Prezista, Lamivudine, Telaprevir, Boceprevir, Reyataz, Ritonavir, Nevirapine

Wider Access to Meds Cuts Global AIDS Deaths in Half

Posted 20 Jul 2017 by Drugs.com

THURSDAY, July 20, 2017 – AIDS-related deaths worldwide have been halved since 2005 as more people were able to get lifesaving drugs, UNAIDS (a United Nations Program) says in a new report. In 2016, 19.5 million (53 percent) of the almost 37 million people living with HIV (the virus that causes AIDS) had access to HIV treatment. AIDS-related deaths fell from 1.9 million in 2005 to 1 million in 2016. If the treatment trend continues, the goal to provide drugs for 30 million HIV patients by 2020 will be achieved, according to the report. "We met the 2015 target of 15 million people on treatment and we are on track to double that number to 30 million and meet the 2020 target," said Michel Sidibe, executive director of UNAIDS. "We will continue to scale up to reach everyone in need and honor our commitment of leaving no one behind," Sidibe said in a program news release. The greatest ... Read more

Related support groups: HIV Infection, Atripla, Tamiflu, Pre-Exposure Prophylaxis, Incivek, Truvada, Stribild, Complera, Baraclude, Victrelis, Oseltamivir, Tenofovir, Viread, Kaletra, Entecavir, Norvir, Lamivudine, Telaprevir, Prezista, Nevirapine

Life Expectancy With HIV Nears Normal With Treatment

Posted 11 May 2017 by Drugs.com

WEDNESDAY, May 10, 2017 – Young adults with HIV who get treatment are living longer in North America and Europe, a new study finds. In fact, a 20-year-old with HIV who began antiretroviral treatment in 2008 or later and had a low viral load after a year of treatment has a life expectancy that's close to that of the general population – around 78 years old, the study found. But life expectancy for people with HIV mostly remains lower than that of the general population, according to the study published in The Lancet HIV. The researchers said their findings could help reduce stigmatization of people with HIV and help them get jobs and medical insurance. The study should also encourage newly diagnosed HIV patients to begin treatment as soon as possible and stick with it. "Our research illustrates a success story of how improved HIV treatments coupled with screening, prevention and ... Read more

Related support groups: HIV Infection, Valtrex, Acyclovir, Tamiflu, Valacyclovir, Pre-Exposure Prophylaxis, Ribavirin, Incivek, Zovirax, Baraclude, Famciclovir, Victrelis, Famvir, Oseltamivir, Tenofovir, Viread, Kaletra, Valcyte, Entecavir, Norvir

Black Americans Still Undertreated for HIV

Posted 3 Feb 2017 by Drugs.com

FRIDAY, Feb. 3, 2017 – Although progress has been made, blacks in America are still being hit harder by HIV/AIDS, a new report from the U.S. Centers for Disease Control and Prevention says. The CDC study found that of more than 12,200 black men and women diagnosed with HIV in 2014, nearly 22 percent had progressed to AIDS by the time they were diagnosed. That means diagnosis and treatment is often coming too late. Moreover, among all black Americans with HIV in 2013, only about 54 percent were receiving continuous medical care. Of those getting care, less than half had effectively suppressed the virus. This is far below the National HIV/AIDS Strategy goals of 90 percent of HIV patients in treatment and 80 percent with undetectable HIV by 2020, the study authors noted. "While we have made great progress in HIV prevention among African Americans in recent years, it is clear that we need ... Read more

Related support groups: HIV Infection, Valtrex, Acyclovir, Tamiflu, Pre-Exposure Prophylaxis, Valacyclovir, Ribavirin, Incivek, Zovirax, Truvada, Baraclude, Famciclovir, Victrelis, Famvir, Oseltamivir, Viread, Tenofovir, Valcyte, Kaletra, Entecavir

Can HIV Drugs Boost Syphilis Risk?

Posted 17 Jan 2017 by Drugs.com

MONDAY, Jan. 16, 2017 – Gay and bisexual men taking antiretroviral drugs to treat HIV infection may be at increased risk for syphilis, new research contends. Based on a review of available evidence, the investigators concluded that the drugs may boost susceptibility to the bacterium that causes syphilis, although the study did not prove cause-and-effect. The finding might explain why new and repeat cases of syphilis in gay and bisexual men have risen sharply compared to other sexually transmitted infections over the past decade, the researchers wrote. The study team was led by Dr. Michael Rekart, from the University of British Columbia's School of Population and Public Health in Vancouver. The findings were published in the Jan. 16 issue of the journal Sexually Transmitted Infections. The authors of an editorial that accompanied the study said the theory is "intriguing" and "warrants ... Read more

Related support groups: HIV Infection, Sexually Transmitted Diseases, Valtrex, Acyclovir, Tamiflu, Pre-Exposure Prophylaxis, Valacyclovir, Ribavirin, Incivek, Zovirax, Syphilis, Baraclude, Famciclovir, Victrelis, Famvir, Oseltamivir, Daklinza, Viread, Tenofovir, Kaletra

Mixed Progress in Worldwide Fight Against HIV/AIDS

Posted 19 Jul 2016 by Drugs.com

TUESDAY, July 19, 2016 – The number of HIV/AIDS deaths worldwide each year has fallen since peaking in 2005, but the number of new HIV infections is up in 74 countries, according to a new study. Deaths from HIV/AIDS fell to 1.2 million in 2015 from 1.8 million in 2005. Though the number of new HIV infections has decreased since a peak of 3.3 million in 1997, it has been relatively stable at about 2.5 million a year for the past decade. Worldwide, new HIV infections fell just 0.7 percent a year between 2005 and 2015, compared to 2.7 percent a year between 1997 and 2005, the study found. Sub-Saharan Africa continued to be a trouble spot, accounting for three-quarters of new HIV infections (1.8 million) in 2015. Last year, south Asia had 8.5 percent (212,500) of new infections; southeast Asia, 4.7 percent (117,500); and east Asia, 2.3 percent (57,500). Between 2005 and 2015, the ... Read more

Related support groups: Infections, HIV Infection, Tamiflu, Pre-Exposure Prophylaxis, Incivek, Baraclude, Victrelis, Oseltamivir, Viread, Tenofovir, Kaletra, Norvir, Entecavir, Prezista, Lamivudine, Telaprevir, Boceprevir, Reyataz, Ritonavir, Nevirapine

Alcohol More Harmful for People With HIV, Study Suggests

Posted 9 Feb 2016 by Drugs.com

MONDAY, Feb. 8, 2016 – Drinking alcohol may be more dangerous for people infected with HIV, a new study suggests. The effects of alcohol appear to be more pronounced for those with the virus that causes AIDS, even when the virus is suppressed with modern antiretroviral treatment (ART), the Yale University researchers reported. They noted that HIV patients who have just one or two drinks a day are at greater risk for death or alcohol-related health issues. The study involved patients treated by the U.S. Department of Veterans Affairs between 2008 and 2012. There were more than 18,000 HIV-positive patients and over 42,000 people not infected with the virus. The researchers investigated the link between drinking alcohol, death and other health issues the patients developed. They found the patients with HIV who drank even moderate amounts of alcohol were more likely to develop ... Read more

Related support groups: HIV Infection, Alcohol Dependence, Tamiflu, Pre-Exposure Prophylaxis, Alcoholism, Incivek, Hangover, Baraclude, Victrelis, Oseltamivir, Viread, Tenofovir, Kaletra, Norvir, Entecavir, Prezista, Lamivudine, Telaprevir, Reyataz, Ritonavir

CDC: Black Americans With HIV Still Less Likely to Get Ongoing Medical Care

Posted 5 Feb 2016 by Drugs.com

FRIDAY, Feb. 5, 2016 – While HIV diagnoses dropped significantly over the past decade in the United States, blacks with HIV are less likely than whites or Hispanics to receive routine, ongoing care, according to the U.S. Centers for Disease Control and Prevention. From 2005 to 2014, annual HIV diagnoses fell 19 percent in the United States. Infections among black women dropped 42 percent during this period. Despite this progress in the fight against HIV, racial disparities persist, the CDC found. While black people make up 12 percent of the U.S. population, they accounted for nearly half of all HIV diagnoses in 2014. "CDC has been working for many years to eliminate the HIV disparities that exist within the black community," Dr. Eugene McCray, director of the CDC's Division of HIV/AIDS Prevention, said in an agency news release. "While we are seeing signs of success, we must continue ... Read more

Related support groups: Harvoni, HIV Infection, Atripla, Tamiflu, Pre-Exposure Prophylaxis, Incivek, Truvada, Triumeq, Stribild, Complera, Genvoya, Baraclude, Victrelis, Oseltamivir, Viread, Tenofovir, Kaletra, Viekira Pak, Norvir, Entecavir

New HIV Treatment Shows Promise in Early Research

Posted 23 Dec 2015 by Drugs.com

WEDNESDAY, Dec. 23, 2015 – Preliminary new research raises the prospect that a recently discovered antibody – an important component of the immune system – could be enlisted to boost the body's response to HIV, the virus that causes AIDS. A single injection of the antibody, currently dubbed VRC01, dramatically reduced the level of HIV in the blood of people who hadn't yet been given antiretroviral drug treatment (ART). ART is the current standard treatment for managing HIV infections, according to the study's authors from the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases in Bethesda, Md. But in people who'd already been treated with ART, the antibody injection had no effect on HIV levels, presumably because the ART therapy had already reduced the levels of HIV virus in their blood, the researchers said. And the researchers were quick to note ... Read more

Related support groups: HIV Infection, Valtrex, Acyclovir, Tamiflu, Pre-Exposure Prophylaxis, Valacyclovir, Ribavirin, Incivek, Zovirax, Baraclude, Famciclovir, Victrelis, Famvir, Oseltamivir, Viread, Tenofovir, Kaletra, Valcyte, Entecavir, Copegus

FDA Lifts Ban on Blood Donations by Gay Men

Posted 21 Dec 2015 by Drugs.com

MONDAY, Dec. 21, 2015 – Gay and bisexual men who have abstained from sex for one year will now be allowed to donate blood in the United States. The new policy, announced Monday by the U.S. Food and Drug Administration, reverses a three-decades-old ban on donations from this group of men that traces back to the start of the AIDS epidemic. "The FDA's responsibility is to maintain a high level of blood product safety for people whose lives depend on it," FDA Acting Commissioner Stephen Ostroff said in an agency news release. "We have taken great care to ensure this policy revision is backed by sound science and continues to protect our blood supply." The FDA said it was changing its policy based on data from other countries that show allowing such donations would not increase the risk of HIV-tainted blood entering America's blood supply. FDA officials have estimated that about half of the ... Read more

Related support groups: Blood Disorders, Bleeding Disorder, Harvoni, HIV Infection, Valtrex, Acyclovir, Anemia, Atripla, Tamiflu, Pre-Exposure Prophylaxis, Valacyclovir, Ribavirin, Incivek, Blood Transfusion, Zovirax, Truvada, Triumeq, Stribild, Complera, Baraclude

Almost Half of American Adults With HIV Don't Take Meds: Report

Posted 24 Sep 2015 by Drugs.com

THURSDAY, Sept. 24, 2015 – Almost half of American adults infected with HIV don't take medications that can prevent them from developing AIDS, a new government report shows. The statistics, based on data gathered from 2007 to 2012, are a few years out of date, so it's not clear whether the situation has changed. Still, the report – an analysis of people aged 18 to 59 – suggests a widespread lack of recommended care. "Based on what we know nowadays, everyone who's HIV-positive should be on therapy," said Dr. Carlos del Rio, co-director of the Center for AIDS Research at Emory University, in Atlanta. "This highlights the challenges we have ahead because we have such an unequal epidemic." The report, authored by Dr. Joseph Woodring of the U.S. National Center for Health Statistics, estimated the prevalence of HIV infection based on a survey of more than 10,000 people. The survey found ... Read more

Related support groups: HIV Infection, Tamiflu, Pre-Exposure Prophylaxis, Sovaldi, Incivek, Baraclude, Sofosbuvir, Victrelis, Oseltamivir, Viread, Tenofovir, Kaletra, Norvir, Entecavir, Telaprevir, Prezista, Lamivudine, Boceprevir, Ritonavir, Reyataz

Early Treatment With Flu Antivirals May Shorten Seniors' Hospital Stay

Posted 3 Sep 2015 by Drugs.com

THURSDAY, Sept. 3, 2015 – Early antiviral treatment for seniors with severe cases of the flu may shorten their hospital stay and reduce the need for extended care after discharge, a new government study finds. "Flu can be extremely serious in older people, leading to hospitalization and, in some cases, long-term disability. This important study shows that people 65 and older should seek medical care early when they develop flu symptoms," Dr. Dan Jernigan, director of the U.S. Centers for Disease Control and Prevention's influenza division, said in an agency news release on the study. People aged 65 and older are at high risk for serious flu complications and should be treated with antiviral drugs as early as possible, according to the CDC. In the study, CDC researchers analyzed data gathered from more than 250 hospitals in 13 states during three consecutive flu seasons (2010-2013), to ... Read more

Related support groups: Influenza, Tamiflu, Oseltamivir, Relenza, Zanamivir, Peramivir, Rapivab

Many U.S. AIDS Patients Still Die When 'Opportunistic' Infections Strike

Posted 1 Jul 2015 by Drugs.com

WEDNESDAY, July 1, 2015 – Even after the advent of powerful medications for suppressing HIV, a new study finds that more than one-third of people in San Francisco who were diagnosed with an AIDS-related infection died within five years. "The main cause of mortality arises from people stopping treatment entirely," said Dr. Robert Grant, a professor at the University of California, San Francisco, who reviewed the findings but was not involved in the research. When HIV treatment lapses, so-called "opportunistic" infections and illnesses can arise, posing a real threat to patients' health, he explained. The bottom line, according to Grant, is that there is still "a long way to go" in prolonging the lives of Americans with HIV/AIDS. The new study was led by Dr. Sandra Schwarcz, associate professor of epidemiology and biostatistics at the University of California, San Francisco. She and her ... Read more

Related support groups: Harvoni, HIV Infection, Atripla, Tamiflu, Pre-Exposure Prophylaxis, Sovaldi, Incivek, Truvada, Triumeq, Stribild, Complera, Baraclude, Sofosbuvir, Victrelis, Mycobacterium avium-intracellulare, Mycobacterium avium-intracellulare - Treatment, Oseltamivir, Tenofovir, Viread, Kaletra

Global Trial Finds HIV Drugs Should Be Taken Right After Diagnosis

Posted 28 May 2015 by Drugs.com

WEDNESDAY, May 27, 2015 – People with HIV should start taking medications to battle the virus that causes AIDS as soon as they're diagnosed, a new international study finds. Scientists involved in the trial were so impressed by the health benefits of early use of HIV drugs that they shut the study down early so they could offer the medications to all participants. The findings could alter World Health Organization guidelines about the best way to treat people with HIV, experts said. Currently, WHO recommends that HIV patients not start treatment until their immune system show signs of weakening. "We now have clear-cut proof that it is of significantly greater health benefit to an HIV-infected person to start antiretroviral therapy sooner rather than later," Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, said in a statement. "Moreover, ... Read more

Related support groups: Harvoni, HIV Infection, Atripla, Tamiflu, Incivek, Truvada, Triumeq, Stribild, Complera, Baraclude, Victrelis, Oseltamivir, Viread, Tenofovir, Kaletra, Norvir, Entecavir, Telaprevir, Lamivudine, Prezista

Ask a Question

Further Information

Related Condition Support Groups

Influenza

Rapivab Patient Information at Drugs.com